Cocrystal Pharma, Inc. SEC filings COCP

Cocrystal Pharma, Inc. has 672 filings in SEC EDGAR's recent list, going back to Sep 20, 2007. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Cocrystal Pharma, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Sep 9, 2026 Sep 9, 2026
8-K Current report
Officer or director change
Aug 18, 2026 Aug 12, 2026
8-K Current report
Regulation FD disclosure
Aug 17, 2026 Aug 17, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 3, 2026 Jul 31, 2026
8-K Current report
Shareholder vote results
Jul 17, 2026 Jul 14, 2026
8-K Current report
Officer or director change
Jun 9, 2026 Jun 3, 2026
8-K Current report
Regulation FD disclosure
Jun 3, 2026 Jun 3, 2026
DEFA14A Additional proxy material May 27, 2026 —
DEF 14A Proxy statement May 27, 2026 May 27, 2026
8-K Current report
Regulation FD disclosure
May 26, 2026 May 26, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
EFFECT Filing May 1, 2026 —
8-K Current report
Regulation FD disclosure
Apr 30, 2026 Apr 30, 2026
CORRESP Letter to the SEC Apr 29, 2026 —
UPLOAD Letter from the SEC Apr 28, 2026 —
S-3 Shelf registration Apr 23, 2026 —
8-K Current report
Regulation FD disclosure
Apr 2, 2026 Apr 2, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 31, 2026 Mar 31, 2026
8-K Current report
Officer or director change
Mar 13, 2026 Mar 10, 2026
8-K Current report
Regulation FD disclosure
Mar 9, 2026 Mar 9, 2026
8-K Current report
Regulation FD disclosure
Feb 19, 2026 Feb 19, 2026
8-K Current report
Officer or director change
Jan 15, 2026 Jan 9, 2026
8-K Current report
Regulation FD disclosure
Dec 18, 2025 Dec 18, 2025
8-K Current report
Regulation FD disclosure
Dec 1, 2025 Dec 1, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 30, 2025 Oct 28, 2025
8-K Current report
Regulation FD disclosure
Oct 27, 2025 Oct 27, 2025
424B3 Prospectus Sep 29, 2025 —
EFFECT Filing Sep 25, 2025 —
CORRESP Letter to the SEC Sep 25, 2025 —
UPLOAD Letter from the SEC Sep 24, 2025 —
S-1 Registration statement Sep 19, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Sep 15, 2025 Sep 12, 2025
424B5 Prospectus supplement Sep 15, 2025 —
8-K Current report
Regulation FD disclosure
Sep 12, 2025 Sep 12, 2025
8-K Current report
Regulation FD disclosure
Sep 12, 2025 Sep 12, 2025
424B3 Prospectus Sep 12, 2025 —
UPLOAD Letter from the SEC Aug 28, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
CORRESP Letter to the SEC Aug 13, 2025 —
8-K Current report
Regulation FD disclosure
Aug 5, 2025 Aug 5, 2025
UPLOAD Letter from the SEC Jul 30, 2025 —
8-K Current report
Regulation FD disclosure
Jul 10, 2025 Jul 10, 2025
8-K Current report
Shareholder vote results
Jul 1, 2025 Jun 25, 2025
8-K Current report
Bylaw or fiscal year change
Jun 18, 2025 Jun 17, 2025
8-K Current report
Regulation FD disclosure
Jun 5, 2025 Jun 5, 2025
8-K Current report
Regulation FD disclosure
May 29, 2025 May 29, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
DEFA14A Additional proxy material May 5, 2025 —
DEF 14A Proxy statement May 5, 2025 May 5, 2025
PRE 14A Preliminary proxy statement Apr 25, 2025 Apr 25, 2025
8-K Current report
Regulation FD disclosure
Apr 24, 2025 Apr 24, 2025
8-K Current report
Regulation FD disclosure
Apr 23, 2025 Apr 23, 2025
8-K Current report
Officer or director change
Apr 8, 2025 Apr 2, 2025
8-K Current report
Other events
Apr 1, 2025 Mar 31, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
8-K Current report
Regulation FD disclosure
Jan 8, 2025 Jan 8, 2025
8-K Current report
Regulation FD disclosure
Dec 31, 2024 Dec 31, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Regulation FD disclosure
Oct 31, 2024 Oct 31, 2024
8-K Current report
Officer or director change
Oct 10, 2024 Oct 9, 2024
8-K Current report
Regulation FD disclosure
Aug 20, 2024 Aug 19, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Regulation FD disclosure
Jul 18, 2024 Jul 18, 2024
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 28, 2024 Jun 25, 2024
8-K Current report
Regulation FD disclosure
Jun 20, 2024 Jun 20, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
DEF 14A Proxy statement May 7, 2024 May 7, 2024
8-K Current report
Regulation FD disclosure
May 1, 2024 May 1, 2024
PRE 14A Preliminary proxy statement Apr 26, 2024 Apr 26, 2024
10-K/A Amended annual report Apr 17, 2024 Dec 31, 2023
10-K Annual report Mar 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 28, 2024 Mar 28, 2024
8-K Current report
Regulation FD disclosure
Mar 19, 2024 Mar 19, 2024
8-K Current report
Agreement ended
Mar 1, 2024 Feb 28, 2024
8-K Current report
Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
8-K Current report
Regulation FD disclosure
Jan 4, 2024 Jan 4, 2024
8-K Current report
Agreement ended
Dec 21, 2023 Dec 15, 2023
8-K Current report
Regulation FD disclosure
Dec 6, 2023 Dec 6, 2023
8-K Current report
Regulation FD disclosure
Dec 4, 2023 Dec 4, 2023
8-K Current report
Regulation FD disclosure
Nov 29, 2023 Nov 28, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Regulation FD disclosure
Oct 31, 2023 Oct 31, 2023
8-K Current report
Results of operations
Aug 16, 2023 Aug 14, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Other events
Jun 15, 2023 Jun 15, 2023
424B5 Prospectus supplement Jun 15, 2023 —
8-K Current report
Shareholder vote results
Jun 12, 2023 Jun 8, 2023
EFFECT Filing May 26, 2023 —
CORRESP Letter to the SEC May 24, 2023 —
S-3/A Filing May 24, 2023 —
UPLOAD Letter from the SEC May 19, 2023 —
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 15, 2023 May 15, 2023
S-3 Shelf registration May 12, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Apr 28, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 24, 2023 Apr 20, 2023
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Apr 10, 2023 Apr 4, 2023
8-K Current report
Other events
Apr 4, 2023 Mar 29, 2023
10-K Annual report Mar 29, 2023 Dec 31, 2022
8-K Current report
Regulation FD disclosure
Mar 15, 2023 Mar 15, 2023
8-K Current report
Regulation FD disclosure
Jan 9, 2023 Jan 9, 2023
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Listing notice, Regulation FD disclosure
Oct 26, 2022 Oct 25, 2022
8-K Current report
Bylaw or fiscal year change
Oct 3, 2022 Sep 27, 2022
8-K Current report
Regulation FD disclosure
Sep 12, 2022 Sep 12, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
8-K Current report
Officer or director change
Jul 29, 2022 Jul 29, 2022
8-K Current report
Shareholder vote results
May 20, 2022 May 18, 2022
8-K Current report
Listing notice
May 19, 2022 May 17, 2022
10-Q Quarterly report May 11, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 11, 2022 May 11, 2022
DEF 14A Proxy statement Apr 11, 2022 Apr 11, 2022
PRE 14A Preliminary proxy statement Apr 1, 2022 Apr 1, 2022
10-K Annual report Mar 23, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 23, 2022 Mar 23, 2022
8-K Current report
Regulation FD disclosure
Dec 22, 2021 Dec 22, 2021
8-K Current report
Listing notice
Nov 19, 2021 Nov 16, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
8-K Current report
Regulation FD disclosure
Sep 14, 2021 Sep 12, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
8-K Current report
Officer or director change
Jul 20, 2021 Jul 16, 2021
8-K Current report
Regulation FD disclosure
Jul 12, 2021 Jul 12, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 21, 2021 Jun 16, 2021
DEFA14A Additional proxy material Jun 7, 2021 —
DEFA14A Additional proxy material Jun 1, 2021 —
DEFA14A Additional proxy material May 28, 2021 —
8-K Current report
Officer or director change
May 28, 2021 May 27, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
8-K Current report
Material agreement
May 5, 2021 May 4, 2021
424B5 Prospectus supplement May 5, 2021 —
8-K Current report
Other events
May 5, 2021 May 4, 2021
DEFA14A Additional proxy material Apr 26, 2021 —
DEF 14A Proxy statement Apr 26, 2021 Apr 26, 2021
PRE 14A Preliminary proxy statement Apr 16, 2021 Apr 16, 2021
10-K Annual report Mar 17, 2021 Dec 31, 2020
8-K Current report
Regulation FD disclosure
Mar 9, 2021 Mar 9, 2021
8-K Current report
Bylaw or fiscal year change
Feb 19, 2021 Feb 14, 2021
8-K Current report
Regulation FD disclosure
Jan 21, 2021 Jan 21, 2021
8-K Current report
Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
8-K Current report
Other events
Dec 18, 2020 Dec 10, 2020
10-Q Quarterly report Nov 13, 2020 Sep 30, 2020
8-K Current report
Listing notice
Nov 6, 2020 Nov 4, 2020
8-K Current report
Other events
Oct 2, 2020 Sep 22, 2020
8-K Current report
Material agreement
Aug 27, 2020 Aug 26, 2020
424B5 Prospectus supplement Aug 27, 2020 —
8-K Current report
Other events
Aug 27, 2020 Aug 26, 2020
8-K Current report
Other events
Aug 27, 2020 Aug 26, 2020
424B5 Prospectus supplement Aug 26, 2020 —
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Material agreement
Jul 2, 2020 Jul 1, 2020
424B5 Prospectus supplement Jul 1, 2020 —
8-K Current report
Officer or director change
Jun 26, 2020 Jun 22, 2020
8-K Current report
Shareholder vote results
Jun 15, 2020 Jun 9, 2020
8-K Current report
Agreement ended
Jun 8, 2020 Jun 2, 2020
EFFECT Filing May 13, 2020 —
10-Q Quarterly report May 13, 2020 Mar 31, 2020
CORRESP Letter to the SEC May 12, 2020 —
CORRESP Letter to the SEC May 11, 2020 —
8-K Current report
Regulation FD disclosure
May 11, 2020 May 11, 2020
S-3/A Filing May 4, 2020 —
CORRESP Letter to the SEC May 4, 2020 —
DEFA14A Additional proxy material Apr 28, 2020 —
DEF 14A Proxy statement Apr 28, 2020 Apr 28, 2020
UPLOAD Letter from the SEC Apr 27, 2020 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 22, 2020 Apr 19, 2020
8-K Current report
Officer or director change
Apr 20, 2020 Apr 15, 2020
S-3 Shelf registration Apr 17, 2020 —
8-K Current report
Results of operations, Other events
Mar 30, 2020 Mar 30, 2020
10-K Annual report Mar 27, 2020 Dec 31, 2019
8-K Current report
Material agreement, Agreement ended, Officer or director change, Regulation FD disclosure, Other events
Mar 13, 2020 Mar 9, 2020
424B5 Prospectus supplement Mar 10, 2020 —
8-K Current report
Regulation FD disclosure
Mar 9, 2020 Mar 6, 2020
8-K Current report
Material agreement, Regulation FD disclosure
Mar 4, 2020 Feb 27, 2020
8-K Current report
Regulation FD disclosure
Mar 4, 2020 Mar 4, 2020
424B5 Prospectus supplement Feb 28, 2020 —
8-K Current report
Material agreement
Feb 24, 2020 Feb 18, 2020
8-K Current report
Regulation FD disclosure
Feb 18, 2020 Feb 18, 2020
424B5 Prospectus supplement Jan 31, 2020 —
8-K Current report
Material agreement
Jan 31, 2020 Jan 29, 2020
424B5 Prospectus supplement Jan 31, 2020 —
8-K Current report
Material agreement
Jan 29, 2020 Jan 29, 2020
8-K Current report
Listing notice
Dec 16, 2019 Dec 13, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Other events
Nov 6, 2019 Nov 4, 2019
424B5 Prospectus supplement Oct 31, 2019 —
424B5 Prospectus supplement Oct 31, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
COCP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bothell, WA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1412486
Former names
BIOZONE PHARMACEUTICALS, INC. (until Mar 25, 2014); International Surf Resorts, Inc. (until Mar 4, 2011)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.